Research study Program year 2019 Source: CMS Open Payments

Phase 12 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies

Research payments

$2,294,761

948 payments

Through program year 2019, $2,294,761 in research payments was reported against Phase 12 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies, across 948 payments, paid by Incyte Corporation.

Paid by: Incyte Corporation
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2019	Research	$2,294,761	948

Breakdown

Who paid Research payments · program year 2019

Incyte Corporation $2,294,761 948 payments

Who received the money Research payments · program year 2019

University of Florida Organisation paid for research $716,062 86 payments
Ut Md Anderson Cancer Center Teaching hospital · TX $351,995 43 payments
The Angeles Clinic and Research Institute Organisation paid for research $350,037 98 payments
University of Oklahoma Health Sciences Center Organisation paid for research $294,240 80 payments
University Of Washington Med Ctr Teaching hospital · WA $223,726 64 payments
Memorial Sloan Kettering Cancer Center Organisation paid for research $90,565 82 payments
Providence Portland Medical Center Teaching hospital · OR $84,931 68 payments
Hackensack University Medical Center Teaching hospital · NJ $45,496 37 payments
American Oncologic Hospial Teaching hospital · PA $43,168 64 payments
Duke University Medical Center Organisation paid for research $20,104 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.